Cargando…

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy

Viruses have evolved various strategies to escape from the innate cellular mechanisms inhibiting viral replication and spread. Extensive evidence has highlighted the ineffectiveness of interferon (IFN) therapy against chronic hepatitis B virus (HBV) infection, implying the existence of mechanisms by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyakawa, Kei, Matsunaga, Satoko, Watashi, Koichi, Sugiyama, Masaya, Kimura, Hirokazu, Yamamoto, Naoki, Mizokami, Masashi, Wakita, Takaji, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673130/ https://www.ncbi.nlm.nih.gov/pubmed/26334101

Ejemplares similares

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
por: Iwamoto, Masashi, et al.
Publicado: (2017)

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
por: Watashi, Koichi, et al.
Publicado: (2014)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Genetic Variation of the IL-28B Promoter Affecting Gene Expression
por: Sugiyama, Masaya, et al.
Publicado: (2011)

BCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction
por: Miyakawa, Kei, et al.
Publicado: (2009)

PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
por: Miyakawa, Kei, et al.
Publicado: (2019)

SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
por: Delobel, Diane, et al.
Publicado: (2022)

H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1
por: Kudoh, Ayumi, et al.
Publicado: (2016)

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction
por: Miyakawa, Kei, et al.
Publicado: (2015)

Unique Evolution of Antiviral Tetherin in Bats
por: Hayward, Joshua A., et al.
Publicado: (2022)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx
por: Murata, Takayuki, et al.
Publicado: (2023)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3
por: Senchi, Kyosuke, et al.
Publicado: (2013)

Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing
por: Ishii, Tomotaka, et al.
Publicado: (2020)

Molecular Evolution of the Primate Antiviral Restriction Factor Tetherin
por: Liu, Jun, et al.
Publicado: (2010)

Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma
por: Fujita, Misuzu, et al.
Publicado: (2022)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein
por: Miyakawa, Kei, et al.
Publicado: (2017)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2
por: Fukuma, Aiko, et al.
Publicado: (2011)

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
por: Kaneko, Manabu, et al.
Publicado: (2018)

Identification of Alternatively Translated Tetherin Isoforms with Differing Antiviral and Signaling Activities
por: Cocka, Luis J., et al.
Publicado: (2012)

Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey
por: Yin, Xin, et al.
Publicado: (2014)

Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
por: Matsumoto, Yoshihiro, et al.
Publicado: (2013)

Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier
por: Ando, Tomomi, et al.
Publicado: (2022)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Structural insights into the HBV receptor and bile acid transporter NTCP
por: Park, Jae-Hyun, et al.
Publicado: (2022)

Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
por: Nie, Yun-Zhong, et al.
Publicado: (2018)

Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction
por: Le Tortorec, Anna, et al.
Publicado: (2011)

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism
por: Arias, Juan F., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9pohdd9crkkl4ufg3ajt2purq0